This IFRS chart of accounts reflects basic IASB guidance.
The advanced, expanded and XBRL cross referenced COAs are suitable for entities that need to produce financial reports fully consistent with all IASB guidance.
Advanced COA Expanded COA With XBRL cross referencesActivate to download all COAs in digital format.
A COA may be incorporated into reporting structure in many ways. Nevertheless, Excel remains the lingua franca of accounting.
On the other hand, some ERP implementation professionals require data structured as CSV or TSV. To accommodate this requirement, read this.
First, ensure you have a functioning version of Python with the Pandas and Openpyxl libraries installed. Next, download the zip file that contains the script Excel-to-CSV.zip. Place both the COA and the script into the same folder. Rename the COA exactly Excel-TSV-Input.xlsx and run the script.
To convert the TSV back, simply copy Excel-TSV-Output.csv to Excel and use the Text to Columns function. Leave the delimiter set to the default Tab. Please be aware, this will strip all formatting, so the Depth column is critical for retaining COA's hierarchy.
Pro view includes additional scripts illustrating how to generate a dynamic hierarchical COA from an Excel source file. It also includes scripts to map the output to balance sheet and P&L in IFRS or US GAAP format (also in Excel).
| Account Title | Account # | Depth | Balance | 1 |
| Assets | 1 | 0 | Dr | 2 |
| Property, plant and equipment | 1.1 | 1 | Dr | 3 |
| Land and land improvements | 1.1.1 | 2 | Dr | 4 |
| Buildings, structures and improvements | 1.1.2 | 2 | Dr | 5 |
| Machinery and equipment | 1.1.3 | 2 | Dr | 6 |
| Fixtures and fittings | 1.1.4 | 2 | Dr | 7 |
| Right of use assets (Classified as PP&E) | 1.1.5 | 2 | Dr | 8 |
As outlined in IFRS 16.47.a.i, an ROU should be classified like the underlying asset if that asset were owned (unless the ROU is presented separately). Thus, the right to use, for example, a building, would be presented in PP&E while the right to use a patent would be intangible (below).
Thus an ROU associated with an underlying asset that is an item of PP&E, it should be recognized as PP&E.
Note: provided the right‑of‑use asset is recognised on the balance sheet, the guidance is flexible about how it is presented. For example, a leased building may be presented within the “Buildings” line item rather than on a separate “right‑of‑use asset” line, as long as the notes explain that the amount relates to a leased (right‑of‑use) building rather than an owned building. From an internal accounting perspective, the building could thus be posted either to the Buildings account with a metadata flag indicating that it is an ROU or to the ROU account with metadata describing the underlying asset as a building.
| Additional property, plant and equipment | 1.1.6 | 2 | Dr | 9 | Construction in progress | 1.1.7 | 2 | Dr | 10 |
| Investment property | 1.2 | 1 | Dr | 11 |
| Completed | 1.2.1 | 2 | Dr | 12 |
| Under construction or development | 1.2.2 | 2 | Dr | 13 |
| Goodwill | 1.3 | 1 | Dr | 14 |
| Intangible assets excluding goodwill | 1.4 | 1 | Dr | 15 |
| Intellectual property | 1.4.1 | 2 | Dr | 16 |
| Computer software | 1.4.2 | 2 | Dr | 17 |
| Trade and distribution assets | 1.4.3 | 2 | Dr | 18 |
| Contracts and rights | 1.4.4 | 2 | Dr | 19 |
| Right of use assets | 1.4.5 | 2 | Dr | 20 |
A right to use an asset is a contractual right. Thus, the right-to-use asset (ROU) is, strictly speaking, always intangible. Nevertheless, as outlined in IFRS 16.47.a.i, an ROU should be classified (unless it is presented separately) in the same way as the underlying asset if it were owned. Thus, an ROU of a building would be presented in PP&E (above) while an ROU of a patent would be presented here.
Note: provided the right‑of‑use asset is recognised on the balance sheet, the guidance is flexible about how it is presented. For example, a leased patent may be presented within the “Patents” group or as a standalone "Patent" rather than as a separate “right‑to‑use patent” item, as long as the notes explain that the amount relates to a leased (right‑of‑use) asset rather than an owned asset. From an internal accounting perspective, a patent could thus be posted either to the Patents account, with a metadata flag indicating that it is an ROU, or to an ROU account, with metadata describing the underlying asset as a patent.
| Crypto assets | 1.4.6 | 2 | Dr | 21 |
While crypto assets have more in common with financial assets than intangible assets, the IFRIC (June 2019 agenda decision) concluded that typical cryptocurrencies meet the definition of an intangible asset under IAS 38, unless they are held for sale in the ordinary course of business, in which case IAS 2 (inventories) applies.
| Additional intangible assets | 1.4.7 | 2 | Dr | 22 |
| Acquisition in progress | 1.4.8 | 2 | Dr | 23 |
| Financial assets and investments | 1.5 | 1 | Dr | 24 |
| Non-derivative financial assets | 1.5.1 | 2 | Dr | 25 |
| Derivative financial assets | 1.5.2 | 2 | Dr | 26 |
| Additional financial assets | 1.5.3 | 2 | Dr | 27 |
| Inventories | 1.6 | 1 | Dr | 29 |
| Merchandise | 1.6.1 | 2 | Dr | 30 |
| Raw materials and production supplies | 1.6.2 | 2 | Dr | 31 |
| Work in progress | 1.6.3 | 2 | Dr | 32 |
| Finished goods | 1.6.4 | 2 | Dr | 33 |
| Other inventories | 1.6.5 | 2 | Dr | 34 |
| Prepayments and accrued income | 1.7 | 1 | Dr | 35 |
| Prepayments | 1.7.1 | 2 | Dr | 36 |
| Accrued income | 1.7.2 | 2 | Dr | 37 |
| Service provider work in process (not classified as inventory) | 1.7.3 | 2 | Dr | 38 |
| Additional assets | 1.7.4 | 2 | Dr | 39 |
| Receivables and contracts | 1.8 | 1 | Dr | 40 |
| Loans and receivables | 1.8.1 | 2 | Dr | 41 |
| Contracts with customers | 1.8.2 | 2 | Dr | 42 |
| Nontrade and other receivables | 1.8.3 | 2 | Dr | 43 |
| Tax assets | 1.9 | 1 | Dr | 44 |
| Tax assets | 1.9.1 | 2 | Dr | 45 |
| Deferred tax assets | 1.9.2 | 2 | Dr | 46 |
| Other tax assets | 1.9.3 | 2 | Dr | 47 |
| Agricultural biological assets | 1.10 | 1 | Dr | 48 |
| Bearer plants | 1.10.1 | 2 | Dr | 49 |
| Animals | 1.10.2 | 2 | Dr | 50 |
| Other agricultural assets | 1.10.3 | 2 | Dr | 51 |
| Cash and cash equivalents | 1.11 | 1 | Dr | 52 |
| Cash | 1.11.1 | 2 | Dr | 53 |
| Cash equivalents | 1.11.2 | 2 | Dr | 54 |
| Restricted cash and financial assets | 1.11.3 | 2 | Dr | 55 |
| Equity | 2 | 0 | (Cr) | 56 |
| Total equity attributable to owners of parent | 2.1 | 1 | (Cr) | 57 |
| Issued capital | 2.1.1 | 2 | (Cr) | 58 |
| Additional item paid-in capital | 2.1.2 | 2 | (Cr) | 59 |
| Partner's capital | 2.1.3 | 2 | (Cr) | 60 |
| Member's equity | 2.1.4 | 2 | (Cr) | 61 |
| Other equity interest | 2.1.5 | 2 | (Cr) | 62 |
| Retained earnings | 2.2 | 1 | Dr or (Cr) | 63 |
| Retained earnings profit loss for reporting period | 2.2.1 | 2 | Dr or (Cr) | 64 |
| Retained earnings excluding profit loss for reporting period | 2.2.2 | 2 | Dr or (Cr) | 65 |
| In suspense | 2.2.3 | 2 | Zero | 66 |
| Accumulated other comprehensive income | 2.3 | 1 | Dr or (Cr) | 67 |
| Accumulated OCI, reserves | 2.3.1 | 2 | Dr or (Cr) | 68 |
| Miscellaneous equity | 2.3.2 | 2 | Dr or (Cr) | 69 |
| Owners equity (non-shareholder) | 2.4 | 1 | (Cr) | 70 |
| Non-controlling interests | 2.5 | 1 | (Cr) | 71 |
| Liabilities | 3 | 0 | (Cr) | 72 |
| Trade and other payables | 3.1 | 1 | (Cr) | 73 |
| Trade payables | 3.1.1 | 2 | (Cr) | 74 |
| Dividend payables | 3.1.2 | 2 | (Cr) | 75 |
| Interest payable | 3.1.3 | 2 | (Cr) | 76 |
| Other payables | 3.1.4 | 2 | (Cr) | 77 |
| Provisions | 3.2 | 1 | (Cr) | 78 |
| Customer related provisions | 3.2.1 | 2 | (Cr) | 79 |
| Litigation and regulatory | 3.2.2 | 2 | (Cr) | 80 |
| Additional provisions | 3.2.3 | 2 | (Cr) | 81 |
| Other financial liabilities | 3.3 | 1 | (Cr) | 82 |
| Notes payable | 3.3.1 | 2 | (Cr) | 83 |
| Loans received | 3.3.2 | 2 | (Cr) | 84 |
| Bonds (debentures) | 3.3.3 | 2 | (Cr) | 85 |
| Other debts and borrowings | 3.3.4 | 2 | (Cr) | 86 |
| Lease obligations | 3.3.5 | 2 | (Cr) | 87 |
| Derivative financial liabilities | 3.3.6 | 2 | (Cr) | 88 |
| Accruals, deferrals and additional liabilities | 3.4 | 1 | (Cr) | 89 |
| Accruals | 3.4.1 | 2 | (Cr) | 90 |
| Deferred income and refund liabilities | 3.4.2 | 2 | (Cr) | 91 |
| Accrued taxes other than payroll | 3.4.3 | 2 | (Cr) | 92 |
| Additional liabilities | 3.4.4 | 2 | (Cr) | 93 |
| Revenue | 4 | 0 | (Cr) | 94 |
| Recognized point of time | 4.1 | 1 | (Cr) | 95 |
| Goods | 4.1.1 | 2 | (Cr) | 96 |
| Services | 4.1.2 | 2 | (Cr) | 97 |
| Recognized over time | 4.2 | 1 | (Cr) | 98 |
| Products and projects | 4.2.1 | 2 | (Cr) | 99 |
| Services | 4.2.2 | 2 | (Cr) | 100 |
| Adjustments | 4.3 | 1 | Dr | 101 |
| Variable consideration | 4.3.1 | 2 | Dr | 102 |
| Consideration paid payable to customers | 4.3.2 | 2 | Dr | 103 |
| Other adjustments | 4.3.3 | 2 | Dr | 104 |
| Expenses | 5 | 0 | Dr | 105 |
| Expenses (classified by nature) | 5.1 | 1 | Dr | 106 |
| Material and merchandise | 5.1.1 | 2 | Dr | 107 |
| Employee benefits expense | 5.1.2 | 2 | Dr | 108 |
| Services expense | 5.1.3 | 2 | Dr | 109 |
| Rent, depreciation, amortization and depletion | 5.1.4 | 2 | Dr | 110 |
| Increase in decrease in inventories of finished goods and work in progress | 5.1.5 | 2 | Dr or (Cr) | 111 |
| Other work performed by entity and capitalized | 5.1.6 | 2 | Dr | 112 |
| Expenses (classified by function) | 5.2 | 1 | Dr | 113 |
For accounting purposes, expenses should be recognized by nature and their function treated as a reporting attribute.
While uncommon in most jurisdictions, in the US, UK or Canada the practice of both recognizing and reporting expenses by function was used even though it led to duplicate accounts such as Employee benefits: Production, Employee benefits: Sales, Employee benefits: Administration or Depreciation: Production equipment, Depreciation: Sales equipment, Depreciation: Office equipment.
The transition to IFRS has made this practice every rare anywhere except the US, where it has also begun to disappear as a reaction to ASC 220-40-50-6.
Nevertheless, as it is not explicitly disallowed, this approach could theoretically be used. As such, it has to be included in this COA as a possible option even though it will almost certainly not ever be used in a real-world setting.
Note: both nature of expense and function of expense classification cannot, obviously, be used for recognition purposes at the same time as this would lead to expense double counting.
| Cost of sales | 5.2.1 | 2 | Dr | 114 |
| Selling, general and administrative | 5.2.2 | 2 | Dr | 115 |
| Other non-operating income and expenses | 6 | 0 | Dr or (Cr) | 116 |
| Other revenue and expenses | 6.1 | 1 | Dr or (Cr) | 117 |
| Other revenue | 6.1.1 | 2 | (Cr) | 118 |
| Other expenses | 6.1.2 | 2 | Dr | 119 |
| Gains and losses | 6.2 | 1 | Dr or (Cr) | 120 |
| Taxes other than income and payroll and fees | 6.3 | 1 | Dr | 121 |
| Tax income (expense) | 6.4 | 1 | Dr or (Cr) | 122 |
| Intercompany and related party accounts | 7 | 0 | Dr or (Cr) | 123 |
| Intercompany and related party assets | 7.1 | 1 | Dr | 124 |
| Intercompany balances eliminated in consolidation | 7.1.1 | 2 | Dr | 125 |
| Related party balances reported or disclosed | 7.1.2 | 2 | Dr | 126 |
| Intercompany investments | 7.1.3 | 2 | Dr | 127 |
| Intercompany and related party liabilities | 7.2 | 1 | (Cr) | 128 |
| Intercompany balances eliminated in consolidation | 7.2.1 | 2 | (Cr) | 129 |
| Related party balances reported or disclosed | 7.2.2 | 2 | (Cr) | 130 |
| Intercompany and related party income and expense | 7.3 | 1 | Dr or (Cr) | 131 |
| Intercompany and related party income | 7.3.1 | 2 | (Cr) | 132 |
| Intercompany and related party expenses | 7.3.2 | 2 | Dr | 133 |
| Income loss from equity method investments | 7.3.3 | 2 | Dr or (Cr) | 134 |
Note: this COA is intentionally formatted so it will retain its key features when copied into Excel.
Updated: May 2026
The IFRS COAs were updated to better reflect upcoming IFRS 18 guidance.
The IASB decided to not update the 2025 XBRL taxonomy for 2026.
The COA published on this page may be republished provided the following citation is provided: